Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the FoF Domestic median (151 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 20 Aug 2025 – 20 Aug 2026, limited by Zerodha Multi Asset Passive FoF. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Zerodha Multi Asset Passive FoF | Nifty 500 |
|---|---|---|
| 20 Aug 2025 | ₹100.00 | ₹100.00 |
| 19 Sep 2025 | ₹103.79 | ₹101.48 |
| 20 Oct 2025 | ₹108.27 | ₹102.48 |
| 19 Nov 2025 | ₹108.43 | ₹103.30 |
| 20 Dec 2025 | ₹109.98 | ₹102.31 |
| 19 Jan 2026 | ₹111.99 | ₹101.00 |
| 19 Feb 2026 | ₹113.64 | ₹100.67 |
| 21 Mar 2026 | ₹106.85 | ₹92.16 |
| 20 Apr 2026 | ₹112.50 | ₹98.80 |
| 21 May 2026 | ₹113.53 | ₹97.67 |
| 20 Jun 2026 | ₹112.67 | ₹100.00 |
| 21 Jul 2026 | ₹113.23 | ₹100.90 |
| 20 Aug 2026 | ₹116.40 | ₹101.60 |
| Metric | Zerodha · Direct NAV ₹11.73 Very High risk ★★★☆☆ 1Y | Category median FoF Domestic · 151 funds |
|---|---|---|
| +16.40% | +8.79% | |
| — | +14.76% | |
| — | +11.89% | |
| — | +12.34% | |
| +16.40% | +11.30% | |
| +12.07% | — | |
| — | +13.06% | |
| — | +10.96% | |
| — | +10.76% | |
| Risk | ||
| 13.44% | 15.95% | |
| 0.74 | 0.81 | |
| 1.02 | 1.14 | |
| -12.66% | -19.45% | |
| Nifty 500 | — | |
| — | +1.81% | |
| — | 0.94 | |
| — | 98.0% | |
| — | 93.1% | |
| 0.23% | 0.17% | |
| ₹163.01Cr | ₹228.08Cr | |
| None | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| — | 11% | |
| Kedarnath Mirajkar · 1.1y | — | |
| 20 Aug 2025 | — | |
| — | — | |
| — | — | |
| -0.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.